Neuromics and Vitro Biopharma Expand Collaboration to Target Drug Discovery and Regenerative Medicine Markets

Posted on by

Neuromics and Vitro Biopharma Expand Collaboration to Target Drug Discovery and Regenerative Medicine Markets

Golden, Colorado - Vitro Diagnostics, Inc. (VODG), dba Vitro Biopharma, announced expansion of its distribution agreement with Neuromics to include targeted sales to select markets in drug discovery & regenerative medicine. Early stages of drug development rely on in-vitro assays to identify effective new drugs and these assays are based on cellular systems. Vitro Biopharmas proprietary stem cell technology allows cost-effective manufacturing of stem cell-derived human cells and multi-cellular constructs that reflect the human in-vivo environment. We have recently developed stem cell-derived cartilage and bone producing cells called chondrocytes and osteoblasts together with various media formulations. We are now offering cells, media and custom services including genetically-engineered cells, to the biopharmaceutical industry specifically focused on drug discovery, development and toxicology for osteoporosis, Pagets disease, osteogenesis imperfecta, bone regeneration & accelerated healing of bone fractures.

This advancement allows us to now combine the distribution channels and sales/marketing expertise of Neuromics with Vitro Biopharmas proprietary technology and manufacturing to target additional markets beyond those presently being pursued in research and clinical development. In addition to markets in drug discovery, we are also pursuing select opportunities within regenerative medicine initially related to expanded use of our high performance and highly competitive MSC-Gro clinical grade media in the expansion of MSCs prior to therapeutic use. Vitro Biopharma is also developing novel stem cell-based products targeting regenerative medicine applications in animals including horses and dogs initially targeting treatment of articular injury, diseases and age-related degeneration.

Pete Shuster, the CEO of Neuromics said, Vitro Biopharmas products have performed well in the hands of our customers. We have years of experience providing primary and progenitor cells to basic and drug discovery researchers and know the importance of having best in class products and services for growing my business.

We now have the opportunity to expand into serving drug discovery for diseases that will need more cost effective treatments with our aging populations. Regenerative therapies using stem cells could prove to the silver bullet. We are working hard to everyday to make this possible

Dr Jim Musick, Vitro Biopharmas CEO, said, We are very pleased to announce our expanded relationship with Neuromics, Inc who has assisted us considerably to expand revenue generated from our products. Our new initiative is fueled by our development of stem-cell derived, differentiated cells including bone/cartilage producing osteoblasts and chondrocytes together with related media products to support use of these cellular systems in the discovery of new drugs for treatment of muscular skeletal diseases such as osteoporosis. While there are several existing drugs for use in treatment of osteoporosis there is a need for new, more effective and safer drugs especially targeting anabolic processes that promote bone generation. Our stem-cell derived human osteoblasts are ideally-suited for use in discovery of new drugs to promote osteoblast function and age-related diminished osteoblast function is a key factor in the generation of osteoporosis. Vitro Biopharma also owns proprietary technology that expands differentiation capacity of adult stem cells to pluripotent levels thus enabling us to expand our offerings of human stem cell derived cellular systems for drug discovery/development applications.

About Neuromics, Inc Neuromics (http://www.neuromics.com), located in Minneapolis, MN, is a privately-held, profitable and growing bio-reagents company. The company was initially built by supplying bio-markers to Neuroscience Researchers. Today, Neuromics provides a range of solutions that include markers, growth factors, gene expression analysis tools, apoptosis detection kits, primary cells and related media. These solutions are increasingly being used in combinations by customers to help accelerate or improve the process of drug discovery. Through the expanded association with Vitro Biopharma, the reagents offered by Neuromics for drug discovery will enhance the capabilities to serve this market sector.

About Vitro Biopharma Vitro Diagnostics, Inc. dba Vitro Biopharma (OTCQB: VODG; http://www.vitrobiopharma.com), owns US patents for production of FSH, immortalization of pituitary cells, and a cell line that produces beta islets for use in treatment of diabetes. In 2011, Vitro Biopharma out-licensed its intellectual property related to treatment of infertility to Dr. James Posillico, a renowned expert in Assisted Reproductive Technologies. Vitro Biopharma also owns a pending US patent for generation of pluripotent stem cells and an additional pending patent for methods of mesenchymal stem cell (MSC) generation and related materials. Vitro Biopharmas mission is Harnessing the Power of Cells for the advancement of regenerative medicine to its full potential. Vitro Biopharma operates within a modern biotechnology manufacturing, R&D and corporate facility in Golden, Colorado. Vitro Biopharma manufactures and sells Tools for Stem Cell and Drug Development, including human mesenchymal stem cells and derivatives, the MSC-Gro Brand of optimized media for MSC self-renewal and lineage-specific differentiation. In addition to our FSH patent licensee, Vitro Biopharma maintains several strategic partnerships including an alliance with Neuromics, Inc. (www.neuromics.com). Neuromics, Inc. is a primary distributor of Vitro Biopharma products and a well established manufacturer and distributor of a large variety of life science research products especially focused on cell-based assay systems We jointly manufacture stem cell assay systems with HemoGenix, Inc. (http://www.hemogenix.com/), known as the LUMENESC quantitative assay for determination of MSC quality, potency and response to toxic agents. Vitro Biopharma has an agreement with Stemgenesis, Inc. (http://www.stemgenesisinc.com) for distribution of its stem cell products into select Chinese provinces. Also, Vitro Biopharmas CEO is a consultant on an NSF grant at the City College of New York to advise Dr. Lane Gilcrest, Professor of Materials Science and Engineering, and his colleagues regarding the development of novel extracellular materials for use in self-renewal and differentiation of mesenchymal stem cells.

Safe Harbor Statement Certain statements contained herein and subsequent statements made by and on behalf of the Company, whether oral or written may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward looking statements are identified by words such as intends, anticipates, believes, expects and hopes and include, without limitation, statements regarding the Companys plan of business operations, product research and development activities, potential contractual arrangements, receipt of working capital, anticipated revenues and related expenditures. Factors that could cause actual results to differ materially include, among others, acceptability of the Companys products in the market place, general economic conditions, receipt of additional working capital, the overall state of the biotechnology industry and other factors set forth in the Companys filings with the Securities and Exchange Commission. Most of these factors are outside the control of the Company. Investors are cautioned not to put undue reliance on forward-looking statements. Except as otherwise required by applicable securities statutes or regulations, the Company disclaims any intent or obligation to update publicly these forward looking statements, whether as a result of new information, future events or otherwise.

CONTACT: Dr. James Musick Chief Executive Officer Vitro Biopharma (303) 999-2130 Ext. 3 E-mail: jim@vitrobiopharma.com

Read more here:

Neuromics and Vitro Biopharma Expand Collaboration to Target Drug Discovery and Regenerative Medicine Markets

Traditional Chinese Medicine Meets American Distance Education

Posted on by

San Francisco, CA (PRWEB) May 14, 2013

This week Saybrook Universitys graduate School of Mind-Body Medicine signed an agreement with the San Francisco based American College of Traditional Chinese Medicine (ACTCM) to explore ways they can bring the best of 21st century western integrative health techniques to those studying traditional Chinese medicine and bring the long-held wisdom of Chinese medicine to mainstream health practitioners.

The partnership will begin with a faculty member from ACTCM developing and teaching a course at Saybrook on Whole Medical Systems that includes the principles of Traditional Chinese Medicine, and will grow to include opportunities for students at each institution to take each others courses. Both institutions anticipate whole new degree offerings coming out of this partnership.

Saybrook University, now in its 41st year, is a pioneer in distance learning. Today it combines online classes with in-person conferences and intensive seminars that give students the flexibility of online learning and the intimacy and immediacy of a classroom experience.

That means many of these new courses in traditional Chinese Medicine will be available to students anywhere in the world.

The partnership agreement was signed on May 1, and the new course offerings are expected to begin in January, 2014

The faculty and administration at ACTCM is very excited about our collaboration with Saybrook University. According to ACTCM President Lixin Huang. Our mutual commitment to integrative medicine and collaborative healthcare makes this an exciting new partnership that will bring benefits to our students, our patients and the communities we serve.

The American College of Traditional Chinese Medicine (ACTCM), founded in 1980, is at the forefront of acupuncture and Traditional Chinese Medicine education. ACTCM has two degree programsthe Master of Science in Traditional Chinese Medicine (MSTCM) and the Doctorate of Acupuncture and Oriental Medicine (DAOM). ACTCM also has an Acupuncture and Herbal Clinic, as well as acupuncture clinics in hospital and community clinic locations in the bay area, which serve as training ground for students, and provide affordable health care services for the community. ACTCM also has certificate programs in Tui Na and Shiatsu body work/medical massage as well as introductory classes for the general public.

Weve known for years that one of the areas our students are most interested in exploring is traditional Chinese medicine. Often its something their patients want to know about, too said Saybrook Provost Dan Sewell. This partnership allows us to be on the forefront of helping offer medical professionals around the country instruction of the highest caliber in this form of traditional healing. Were very excited.

Saybrooks School of Mind-Body Medicine was founded in 2009 by some of the leading practitioners of integrative health, including Dr. James Gordon, founder of the Center for Mind-Body Medicine in Washington, D.C., and Dr. Donald Moss, a past-president of the American Psychological Associations division on medical hypnosis and a board member of the Biofeedback Certification International Alliance, among other distinctions. It offers M.S. and PhD degrees in Mind-Body Medicine, including specializations in research, practice, health care systems management, and integrative mental health. It also offers Certificates in Mind-Body Medicine, Health and Wellness Coaching, Clinical Hypnosis, and Biofeedback and Neurofeedback to non-degree students.

The rest is here:

Traditional Chinese Medicine Meets American Distance Education

Volleyball Superstar, Healthy Living Expert Gabby Reece Selects National Academy of Sports Medicine

Posted on by

CHANDLER, Ariz.--(BUSINESS WIRE)--

TheNational Academy of Sports Medicine, a global leader in evidence-based certified personal training, today announcesGabby Reece, a portrait of fitness and health, is taking on her next big challenge, becoming a NASM Certified Personal Trainer.

A professional volleyball legend whose popularity and success launched careers as a sports announcer, model, actress and author, Reeces newest adventure is one that will continue to inspire her fans. She is utilizing NASMs extensive educational resources to develop a series of articles on fitness, nutrition and healthy living to share with her global following, while becoming a NASM Certified Personal Trainer. Reece will provide advice on exercise, proper diet and overall well-being, as well as blog about her journey on her highly popular website, GabbyandLaird.com, as she earns the industrys most sought-after and highly respected certification NASMs Certified Personal Trainer (CPT).

My entire career has been built on health and fitness, and I want to continue to educate myself in order to better inspire others to achieve their personal fitness goals, as well as enjoy all the benefits of healthy living, Reece said. Staying healthy and being fit is an ongoing journey, and I believe the combination of regular physical activity and proper nutrition has the power to transform lives, instill confidence and bring out the best in people.

Reece is currently studying for the CPT exam, a rigorous test that ensures proficiency in fitness assessments and training techniques, muscle groups, weight-loss measures and nutrition. The certification is considered the gold standard in the industry, reserved for the most respected certified personal trainers in the country.

Gabby Reece is anexceptionalathlete who wasinfluential toboth men and women and helped to grow the popularity of sand volleyball. But, what resonates is that she has continued to be a rolemodeloff the volleyball court. Evenaftershe stopped competing, she never let go of the idea of fitness and how it can improve one's quality of life, said Andrew Wyant, president of NASM.

For the most part, Reece will use her certification to further her personal knowledge about fitness and will share her tips on GabbyandLaird.com, a website she developed with husband and world-famous surfer Laird Hamilton. Their site gives practical advice on nutrition, fitness and self-motivation all through the lens of two experienced athletes with extensive firsthand knowledge on how to optimize the results of a fitness program. Visitors will find useful articles, suggested workouts, video tutorials, plus easily applicable tips and personal anecdotes from both Reece and Hamilton.

For more information about the NASM CPT that Reece is pursuing, visit http://www.nasm.org.

About NASM

Since 1987, the National Academy of Sports Medicine (NASM) has been a global leader in providing evidence-based certifications and advanced credentials to health and fitness professionals. In addition to its NCCA-accredited fitness Certified Personal Trainer (CPT) certification, NASM offers a progressive career track with access to Advanced Specializations including the Corrective Exercise Specialist (CES), Performance Enhancement Specialist (PES), Continuing Education courses, and accredited Bachelor and Master Degree programs. The NASM educational continuum is designed to help todays health and fitness professional enhance their career while empowering their clients to live healthier lives.

Read this article:

Volleyball Superstar, Healthy Living Expert Gabby Reece Selects National Academy of Sports Medicine

Institute of Medicine: Lowering daily sodium intake below 2,300 milligrams may do more harm than good

Posted on by

A report from the Institute of Medicine (IOM) suggests that lowering sodium below 2,300 milligrams per day may be harmful to your health.

While the organization, which is the health section of the non-profit organization the National Academy of Sciences, says that Americans are eating too much salt in their diets currently, their research has led them to conclude that lowering sodium too much may increase other adverse health risks.

"These new studies support previous findings that reducing sodium from very high intake levels to moderate levels improves health," committee chair Brian Strom, George S. Pepper Professor of Public Health and Preventive Medicine at the University of Pennsylvania Perelman School of Medicine, said in a press release. "But they also suggest that lowering sodium intake too much may actually increase a person's risk of some health problems."

Currently, the average American Adult consumes 3,400 milligrams or more of sodium a day or about 1.5 teaspoons of salt.

The current Dietary Guidelines for Americans suggests that people 14 to 50 should limit their salt intake to 2,300 milligrams daily. People 51 or older, African Americans and people with hypertension, diabetes or chronic kidney disease are recommended to keep their sodium levels below 1,500 milligrams in general. For reference, the American Heart Association (AHA) recommends that people stay below 1,500 milligrams per day to avoid heart disease and stroke risk, regardless of age, race or ethnicity.

Play Video

High levels of sodium may be linked to one-third of Americans who have high blood pressure because the extra salt retains extra fluid in the body, making the heart work harder. High salt content has also been linked to increased risk for stroke, heart failure, osteoporosis, stomach cancer and kidney disease.

While the IOM committee found that higher levels of sodium consumption increased heart disease risk, they said studies on health outcomes are inconsistent and insufficient when it comes to whether lowering salt intake to below 2,300 can decrease the risk of heart disease, stroke or all-cause mortality.

In addition, low sodium intake was shown to have negative health affects for those with mid-to-late stage heart failure. There was also not that much evidence showing the effect of low salt consumption and other subgroups, including African Americans, people over 51 and those with health conditions like diabetes, kidney disease, hypertension or borderline hypertension.

The IOM called for more research into low sodium levels between 1,500 to 2,300 milligrams per day and the various health consequences for all people.

Read the original here:

Institute of Medicine: Lowering daily sodium intake below 2,300 milligrams may do more harm than good

Cancer Genetics to Sponsor and Host Roundtable at BioNJ Diagnostics & Personalized Medicine Innovation Summit

Posted on by

RUTHERFORD, N.J.--(BUSINESS WIRE)--

Cancer Genetics, Inc. (CGIX) ("CGI" or the "Company"), a leader in oncology-focused personalized medicine, will sponsor and host a roundtable discussion at the second annual BioNJ Diagnostics & Personalized Medicine Innovation Summit on Thursday, June 6, 2013 at Sanofis U.S. headquarters in Bridgewater, NJ.

The BioNJ Diagnostics & Personalized Medicine Innovation Summit will bring together leaders from major global biotechnology and pharmaceutical companies, diagnostics companies, and emerging innovator companies to discuss the latest trends, developments and challenges in the evolution and adoption of personalized medicine. The all-day event will include company presentations, networking opportunities, and moderated panel discussions focused on research and commercialization challenges in diagnostics and personalized medicine.

Panna Sharma, CEO and President of CGI, will moderate a morning roundtable discussion that will offer a cross-industry perspective from thought leaders and operators in the frontline of driving personalized medicine. The panel will discuss trends and strategies that are emerging among leading companies in personalized medicine. Panelists include:

To learn more about the BioNJ Diagnostics & Personalized Medicine Innovation Summit, visit http://www.bionj.org/diagnostics-and-personalized-medicine-innovation-summit.

About Cancer Genetics, Inc.

Cancer Genetics, Inc. (CGI) is an emerging leader in DNA-based cancer diagnostics and servicessome of the most prestigious medical institutions in the world. Our tests target cancers that are difficult to diagnose and predict treatment outcomes. These cancers include hematological, urogenital and HPV-associated cancers. We also provide a comprehensive range of non-proprietary oncology-focused tests and laboratory services.

CGIs cutting-edge proprietary tests and state-of-the-art reference laboratory provide critical genomic information to healthcare professionals as well as biopharma and biotech. Our state-of-the-art reference lab is focused entirely on maintaining clinical excellence and is both CLIA certified and CAP accredited and has licensure from several states including New York State.

Founded in 1999 by world-renowned cytogeneticist Dr. R.S.K. Chaganti, the Company has been built on a foundation of world-class scientific knowledge and IP in solid and blood-borne cancers, and has established strong research collaborations with major cancer centers such as Memorial Sloan-Kettering, The Cleveland Clinic and the National Cancer Institute. For further information, please seewww.cancergenetics.com.

Continued here:

Cancer Genetics to Sponsor and Host Roundtable at BioNJ Diagnostics & Personalized Medicine Innovation Summit

Institute of Medicine: Lowering daily sodium intake below 2,300 may be bad

Posted on by

A report from the Institute of Medicine (IOM) suggests that lowering sodium below 2,300 milligrams per day may be harmful to your health.

While the organization, which is the health section of the non-profit organization the National Academy of Sciences, says that Americans are eating too much salt in their diets currently, their research has led them to conclude that lowering sodium too much may increase other adverse health risks.

"These new studies support previous findings that reducing sodium from very high intake levels to moderate levels improves health," committee chair Brian Strom, George S. Pepper Professor of Public Health and Preventive Medicine at the University of Pennsylvania Perelman School of Medicine, said in a press release. "But they also suggest that lowering sodium intake too much may actually increase a person's risk of some health problems."

Currently, the average American Adult consumes 3,400 milligrams or more of sodium a day or about 1.5 teaspoons of salt.

The current Dietary Guidelines for Americans suggests that people 14 to 50 should limit their salt intake to 2,300 milligrams daily. People 51 or older, African Americans and people with hypertension, diabetes or chronic kidney disease are recommended to keep their sodium levels below 1,500 milligrams in general. For reference, the American Heart Association (AHA) recommends that people stay below 1,500 milligrams per day to avoid heart disease and stroke risk, regardless of age, race or ethnicity.

Play Video

High levels of sodium may be linked to one-third of Americans who have high blood pressure because the extra salt retains extra fluid in the body, making the heart work harder. High salt content has also been linked to increased risk for stroke, heart failure, osteoporosis, stomach cancer and kidney disease.

While the IOM committee found that higher levels of sodium consumption increased heart disease risk, they said studies on health outcomes are inconsistent and insufficient when it comes to whether lowering salt intake to below 2,300 can decrease the risk of heart disease, stroke or all-cause mortality.

In addition, low sodium intake was shown to have negative health affects for those with mid-to-late stage heart failure. There was also not that much evidence showing the effect of low salt consumption and other subgroups, including African Americans, people over 51 and those with health conditions like diabetes, kidney disease, hypertension or borderline hypertension.

The IOM called for more research into low sodium levels between 1,500 to 2,300 milligrams per day and the various health consequences for all people.

See original here:

Institute of Medicine: Lowering daily sodium intake below 2,300 may be bad

Personalized Medicine Market Analysis

Posted on by

NEW YORK, May 15, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Personalized Medicine Market Analysis

http://www.reportlinker.com/p0444446/Personalized-Medicine-Market-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Therapy

Advancements in the field of genomics have created ample opportunities for personalized medicines to emerge in the healthcare industry. Personalized medicine represents an interface of therapeutics and diagnostics. It involves the tailoring of treatments as per individuals. The growing research applications and identification of molecular markers towards disease predisposition and progression have led to the growth of personalized medicine. Industry players have also rapidly adopted this field and are progressing towards achieving higher goals in the same.

According to our new research report, "Personalized Medicine Market Analysis", the U.S. represents the brightest market for personalized medicine and is anticipated to grow at a CAGR of around 9.5% during 2012-2017. The need for rapid detection of diseases, especially cancer,and their more efficient treatments are primarily driving this market.

Besides USA, countries like the U.K., France, Germany, India, China, and Japan have also been trying to pioneer personalized medicine with the help of advanced technologies. A lot of investment has been undergoing for research and development to develop biomarkers and personalized healthcare solutions in order to improve the medical outcomes. Our report provides a prudent analysis at the country level, elucidating the level of personalized medicine penetration, recent industry developments and the future growth prospects.

Read the rest here:

Personalized Medicine Market Analysis

Medical School Pathology, 2013 Season, Session #60: Environmental Nutritional II – Video

Posted on by


Medical School Pathology, 2013 Season, Session #60: Environmental Nutritional II
Medical School Pathology, 2013 Season, Session #60: Environmental Nutritional II This is session #60 of 63 sessions of a medical school pathology course taug...

By: WashingtonDeceit

See the original post here:

Medical School Pathology, 2013 Season, Session #60: Environmental Nutritional II - Video

EpiPen: Injectable Adrenaline, with Vincent Vega! – One Minute Medical School – Video

Posted on by


EpiPen: Injectable Adrenaline, with Vincent Vega! - One Minute Medical School
Ever wonder how an EpiPen treats a severe allergic reaction? How about why Vince Vega injected adrenaline into Marcellus Wallace #39;s wife #39;s heart? Dr Rob can a...

By: OneMinuteMedSchool

Read the original here:

EpiPen: Injectable Adrenaline, with Vincent Vega! - One Minute Medical School - Video

10 Private Medical Schools With the Lowest Price Tags

Posted on by

The U.S. News Short List, separate from our overall rankings, is a regular series that magnifies individual data points in hopes of providing students and parents a way to find which undergraduate or graduate programs excel or have room to grow in specific areas. Be sure to explore The Short List: College and The Short List: Grad School to find data that matters to you in your college or grad school search.

Ben Bernanke, chairman of the Federal Reserve, admitted his shock at the price tag of medical education in a congressional hearing last year. "My son in medical school recently informed me that he expects to have $400,000 in debt when he graduates from school," he said in front of the House Committee on Financial Services.

That Bernanke, who had an estimated net worth between $850,000 and $1.9 million in 2008, according to the Associated Press, was jolted by the cost of his son's medical education should come as no surprise. These days, even wealthy families can't escape the staggering cost of medical school.

[Prepare for the MCAT without breaking the bank.]

For the 2012-2013 year, the average total cost for tuition and fees for nonresident, first-year medical students at private schools is $49,897, about $3,600 less than the total for nonresidents of public institutions, according to the Association of American Medical Colleges.

Of the top 10 least expensive private medical schools, Baylor College of Medicine continues to be the cheapest, with out-of-state tuition and fees totaling $30,068 for the 2012-2013 school year. Baylor was one of 47 ranked private schools that reported data to U.S. News in the fall of 2012.

The Medical College of Wisconsin had the highest price tag on the list, $45,179, landing in the No. 10 spot. The School of Medicine at Wake Forest University held this spot last year. Although the total for Wake Forest tuition and fees increased by more than $3,000 since the 2011-2012 school year, it now places ninth on the list.

[Save for medical school with a 529 plan.]

The average price for out-of-state tuition plus fees for the 10 least expensive schools is $38,619, almost $10,000 less than the average for all private medical schools. Out of all 47 schools, the School of Medicine at Tufts University was the most expensive, with tuition and fees totaling more than $55,000. Unranked schools, which did not meet certain criteria required by U.S. News to be numerically ranked, were not considered for this report.

Below is a list of the 10 least expensive private medical schools based on tuition and required fees.

Read the original here:

10 Private Medical Schools With the Lowest Price Tags

LSU Medical School in Shreveport could close in January

Posted on by

As the state budget stands right now, the LSU Medical School in Shreveport will have to close next January.

Chancellor Dr. Robert Barish and Vice Chancellor of Clinical Affairs Dr. Hugh Mighty spoke in front of the Senate Finance Committee Monday in Baton Rouge to explain their financial situation.

If I depend on just on what you've budgeted, we would only have funding for about seven months, said Mighty.

According to Mighty, the med school will be short $42 million in the 2013-14 fiscal year starting in July.

Since its inception, the Med School has been partially funded by the hospital. The money it would give the Med School would come from reimbursements the state gave to it for the care of people on Medicaid and the uninsured.

Some of that money comes the Federal government, but last year the Feds cut back on the money it gives the state, so the hospital doesn't have the cash to fund the med school.

During the committee meeting, Sen. Eric LaFleur, (D) Ville Platte, asked, So if you can't sustain the school, do you have prediction on what would happen later in the year [2014]?

If we can't sustain the school it will go out of business obviously which will deal a great blow to the state, responded Mighty.

If the school closes that would mean nearly 900 students in Shreveport would be affected, but both Mighty and Chancelor Barish said they will not allow the school to close.

It's a stretch and a challenge to find a solution but we must find a solution, said Mighty.

Read this article:

LSU Medical School in Shreveport could close in January

How A Florida Medical School Cares For Communities In Need

Posted on by

With community-based health care a central part of its curriculum, Florida International University's medical school turned an RV into a mobile health clinic so that students could treat families in neighborhoods where medical care is scare.

With community-based health care a central part of its curriculum, Florida International University's medical school turned an RV into a mobile health clinic so that students could treat families in neighborhoods where medical care is scare.

If it's a Monday, you can usually find Dr. David Brown parked next to a lake in Miami, spending the day inside a 36-foot-long RV. He's not on vacation.

Brown is chief of family medicine at Florida International University's medical school. The RV is the school's mobile health clinic.

Every Monday it's parked at the Royal Country Mobile Home Park in northwest Miami-Dade County. "It's a beautiful place right here," he says. "But this is not a wealthy community."

Brown helps direct FIU's Neighborhood HELP program. It's part of the school's curriculum that connects medical students with families in neighborhoods where medical care is scarce.

Students visit families in their homes where they conduct examinations and provide basic care. But some things are better done in a clinic. So the medical school bought its own RV. "We're able to bring free basic primary care to our households relatively close to their community," Brown says.

In one of the RV's exam rooms, third-year medical student Veronica Alvarez met recently with patient Maritza Flores. Flores has diabetes and high blood pressure. With help from the school's faculty, Alvarez has been treating her since January.

Flores says with Alvarez's encouragement, she's begun exercising more and has improved her diet. And, thanks to FIU's doctors, she's begun taking medication for her diabetes and high blood pressure. In just a few months, Alvarez says, she's seen a big improvement. "The high blood pressure and the diabetes together is what you worry about," Alvarez says. "And now, her diabetes is well-controlled and her hypertension is well-controlled as well."

Over the last decade, a pressing need for new doctors has led many universities to open medical schools. Seventeen new schools have been accredited since 2005, and several are looking at new ways to train doctors.

Read more:

How A Florida Medical School Cares For Communities In Need